| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Department of Pharmacology (M.I., T.L.W., A.H., G.C.W.), University of Vermont College of Medicine, Burlington, Vt; Department of Neurosurgery (M.I.), Sapporo Medical University, Sapporo, Japan; and the Department of Surgery (S.R.R., B.L.T., G.C.W.), Division of Neurological Surgery, University of Vermont College of Medicine, Burlington, Vt.
Correspondence to George C. Wellman, PhD, University of Vermont, Department of Pharmacology, Given Building, 89 Beaumont Ave, Burlington, VT 054050068. E-mail george.wellman{at}uvm.edu
Cerebral aneurysm rupture and subarachnoid hemorrhage (SAH) inflict disability and death on thousands of individuals each year. In addition to vasospasm in large diameter arteries, enhanced constriction of resistance arteries within the cerebral vasculature may contribute to decreased cerebral blood flow and the development of delayed neurological deficits after SAH. In this study, we provide novel evidence that SAH leads to enhanced Ca2+ entry in myocytes of small diameter cerebral arteries through the emergence of R-type voltage-dependent Ca2+ channels (VDCCs) encoded by the gene CaV 2.3. Using in vitro diameter measurements and patch clamp electrophysiology, we have found that L-type VDCC antagonists abolish cerebral artery constriction and block VDCC currents in cerebral artery myocytes from healthy animals. However, 5 days after the intracisternal injection of blood into rabbits to mimic SAH, cerebral artery constriction and VDCC currents were enhanced and partially resistant to L-type VDCC blockers. Further, SNX-482, a blocker of R-type Ca2+ channels, reduced constriction and membrane currents in cerebral arteries from SAH animals, but was without effect on cerebral arteries of healthy animals. Consistent with our biophysical and functional data, cerebral arteries from healthy animals were found to express only L-type VDCCs (CaV 1.2), whereas after SAH, cerebral arteries were found to express both CaV 1.2 and CaV 2.3. We propose that R-type VDCCs may contribute to enhanced cerebral artery constriction after SAH and may represent a novel therapeutic target in the treatment of neurological deficits after SAH.
Key Words: calcium channels vascular smooth muscle cerebral arteries subarachnoid hemorrhage
1E
This article has been cited by other articles:
![]() |
M. A. Nystoriak, K. Murakami, P. L. Penar, and G. C. Wellman Cav1.2 splice variant with exon 9* is critical for regulation of cerebral artery diameter Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1820 - H1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng, J. Pachuau, E. Blaskova, M. Asuncion-Chin, J. Liu, A. M. Dopico, and J. H. Jaggar Alternative splicing of Cav1.2 channel exons in smooth muscle cells of resistance-size arteries generates currents with unique electrophysiological properties Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H680 - H688. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Link, K. Murakami, M. Beem-Miller, B. I. Tranmer, and G. C. Wellman Oxyhemoglobin-Induced Expression of R-Type Ca2+ Channels in Cerebral Arteries Stroke, July 1, 2008; 39(7): 2122 - 2128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1750 - H1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nikitina, Z.-D. Zhang, A. Kawashima, B. S. Jahromi, V. A. Bouryi, M. Takahashi, A. Xie, and R. L. Macdonald Voltage-dependent calcium channels of dog basilar artery J. Physiol., April 15, 2007; 580(2): 523 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishiguro, A. D. Morielli, K. Zvarova, B. I. Tranmer, P. L. Penar, and G. C. Wellman Oxyhemoglobin-Induced Suppression of Voltage-Dependent K+ Channels in Cerebral Arteries by Enhanced Tyrosine Kinase Activity Circ. Res., November 24, 2006; 99(11): 1252 - 1260. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |